Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · STATUTE-COMPILATIONS · Food and Drug Administration Safety and Innovation Act · Sec. 603

Sec. 603. AGENCY DOCUMENTATION AND REVIEW OF SIGNIFICANT DECISIONS

391 words·~2 min read·/statute-compilations/comps-9932/sec-603

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 603 AGENCY DOCUMENTATION AND REVIEW OF SIGNIFICANT DECISIONS Chapter V is amended by inserting after section 517 (21 U.S.C. 360g) the following: > > ## “SEC. 517A AGENCY DOCUMENTATION AND REVIEW OF SIGNIFICANT DECISIONS REGARDING DEVICES > > > ### “(a) Documentation of Rationale for Significant Decisions > > > #### “(1) In general > > The Secretary shall provide a substantive summary of the scientific and regulatory rationale for any significant decision of the Center for Devices and Radiological Health regarding submission or review of a report under section 510(k), an application under section 515, or an application for an exemption under section 520(g), including documentation of significant controversies or differences of opinion and the resolution of such controversies or differences of opinion. > > > #### “(2) Provision of documentation > > Upon request, the Secretary shall furnish such substantive summary to the person who is seeking to submit, or who has submitted, such report or application. > > > ### “(b) Review of Significant Decisions > > > #### “(1) Request for supervisory review of significant decision > > Any person may request a supervisory review of the significant decision described in subsection (a)(1).
Such review may be conducted at the next supervisory level or higher above the individual who made the significant decision. > > > #### “(2) Submission of request > > A person requesting a supervisory review under paragraph
(1)shall submit such request to the Secretary not later than 30 days after such decision and shall indicate in the request whether such person seeks an in-person meeting or a teleconference review. > > > #### “(3) Timeframe > > > ##### “(A) In general > > Except as provided in subparagraph (B), the Secretary shall schedule an in-person or teleconference review, if so requested, not later than 30 days after such request is made. The Secretary shall issue a decision to the person requesting a review under this subsection not later than 45 days after the request is made under paragraph (1), or, in the case of a person who requests an in-person meeting or teleconference, 30 days after such meeting or teleconference. > > > ##### “(B) Exception > > Subparagraph
(A)shall not apply in cases that are referred to experts outside of the Food and Drug Administration.” > .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 603
AGENCY DOCUMENTATION AND REVIEW OF SIGNIFICANT DECISIONS
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.